Robert Schrepfer
Overview
Robert Schrepfer received an average of $1M in total compensation, including $340K in salary, at ANI Pharmaceuticals from 2013 to 2020.
2020ANI PharmaceuticalsFormer Senior Vice President, New Business Development and Specialty Sales
2019ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2018ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2017ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2016ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2015ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2014ANI PharmaceuticalsSenior Vice President, New Business Development and Specialty Sales
2013ANI PharmaceuticalsVice President, New Business Development and Contract Manufacturing
Source: SEC filings on April 29, 2021, April 23, 2020, April 4, 2019, April 6, 2018, April 6, 2017, and April 14, 2016.
Related executives
We found 11 more executives who work or worked at ANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
Charlotte Arnold
ANI Pharmaceuticals